However, despite being very rare, children older than five years of age are not completely protected from this condition, as a few cases of hypertrophic cardiomyopathy developing after growth hormone therapy have been observed in children with NS at 6–8 years of age (Dahlgren, personal communication). The gene discussed is GH1; the disease is hypertrophic cardiomyopathy.